Jodi Regts
Public Communications Contact at XENON PHARMACEUTICALS INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ian Mortimer | M | 48 | 27 years | |
| Simon Pimstone | M | 56 | 28 years | |
| Victor Manuel Diaz | M | 64 |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 17 years |
| Andrew Berkeley | M | - | 11 years | |
| Suzanne Foster | F | 54 | - | |
| Andrea DiFabio | F | 55 | 2 years | |
| Mohammad Azab | M | 68 | 21 years | |
| Dawn Svoronos | F | 70 | 8 years | |
| Elizabeth Garofalo | M | 66 | 3 years | |
| Clarence Machado | M | 60 | 4 years | |
| Steven Gannon | M | 62 | 9 years | |
| M. Thomas Boon | M | - | - | |
| Adrian Mendes | M | - | 1 years | |
| Gary Patou | M | 65 | 20 years | |
| David Mussafer | M | 60 | 10 years | |
| Sherry Aulin | F | 40 | 13 years | |
| Michael Rogawski | M | - | - | |
| Josh Vose | M | - | 1 years | |
| Christopher Kenney | M | - | 3 years | |
| Anantha Kancherla | M | - | 2 years | |
| Sara Brien | F | - | 1 years | |
| Sarah Butler | M | - | 3 years | |
| James Empfield | M | - | 8 years | |
| Gillian Cannon | M | 60 | 1 years | |
| Chris von Seggern | M | - | 4 years | |
| Carl Gazdzinski | M | - | - | |
| Robin Sherrington | M | 63 | 23 years | |
| Shelley McCloskey | F | 64 | 5 years | |
| Sheila M. Grant | F | - | 4 years | |
| Aaron Davidson | M | 55 | 4 years | |
| Hugh Cleland | M | - | 7 years | |
| Justin Gover | M | 53 | 1 years | |
| Adam Hodges | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Frank Holler | M | 67 | 25 years | |
| Michael Hayden | M | 72 | 26 years | |
| Christine Day | F | 61 | 6 years | |
| Tammy Neske | F | 53 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | - |
| Gary Ingenito | M | 68 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 3 years |
| Clarissa Desjardins | M | 57 | - | |
| Bruce G. Cousins | M | 63 | 5 years | |
| Y. Paul Goldberg | M | 64 | 18 years | |
| Diane Gardiner | F | - |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | 6 years |
| Richard Scheller | M | 70 | 5 years | |
| Steven Collins | M | 55 | 3 years | |
| Ronald Ian Lennox | M | 71 | 4 years | |
| Arthur M. Bruskin | M | - | 4 years | |
| Michael Tarnow | M | 79 | 22 years | |
| Mark Owens Thornton | M | 66 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 1 years |
| Michelle Seltenrich | F | - |
Forbes Medi-Tech, Inc.
 Forbes Medi-Tech, Inc. Pharmaceuticals: MajorHealth Technology Forbes Medi-Tech, Inc. develops and markets a portfolio of nutraceutical products, including functional foods and supplement for the benefit of all consumers. The company provides value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Rewrite as 'It is a life sciences company focused on evidence-based nutritional solutions. It has successfully developed and commercialized its Reducol(tm) plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower 'LDL' cholesterol levels safely and naturally. It was founded on September 17, 1985 and is headquartered in Vancouver, Canada | 4 years |
| Lee Holman | M | - | 3 years | |
| Kathryn Henry | F | 58 | 4 years | |
| Kamran Alam | M | 50 |
The Centre for Drug Research & Development
The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | 2 years |
| Hugues Sachot | M | - |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 6 years |
| Ernesto Aycardi | M | 61 | 3 years | |
| Nousheen Huq | F | 53 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 7 years |
| Erick DeVinney | M | 48 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 2 years |
| Mark M. Kowalski | M | 69 | 3 years | |
| Gregory Anderson | M | 77 |
Forbes Medi-Tech, Inc.
Forbes Medi-Tech, Inc. Pharmaceuticals: MajorHealth Technology Forbes Medi-Tech, Inc. develops and markets a portfolio of nutraceutical products, including functional foods and supplement for the benefit of all consumers. The company provides value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Rewrite as 'It is a life sciences company focused on evidence-based nutritional solutions. It has successfully developed and commercialized its Reducol(tm) plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower 'LDL' cholesterol levels safely and naturally. It was founded on September 17, 1985 and is headquartered in Vancouver, Canada | 2 years |
| Laura Brege | F | 66 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 4 years |
| Jeffrey P. Walker | M | 72 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | - |
| Jay Bernard Dent | M | 65 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | - |
| Christopher John Wesley Dennis | M | 65 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 1 years |
| Philip Toleikis | M | - |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 7 years |
| David M. Gravett | M | 58 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 3 years |
| Greg Peet | M | 70 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 3 years |
| Jeffrey J. E. Motley | M | - |
Forbes Medi-Tech, Inc.
Forbes Medi-Tech, Inc. Pharmaceuticals: MajorHealth Technology Forbes Medi-Tech, Inc. develops and markets a portfolio of nutraceutical products, including functional foods and supplement for the benefit of all consumers. The company provides value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Rewrite as 'It is a life sciences company focused on evidence-based nutritional solutions. It has successfully developed and commercialized its Reducol(tm) plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower 'LDL' cholesterol levels safely and naturally. It was founded on September 17, 1985 and is headquartered in Vancouver, Canada | 8 years |
| Percy Skuy | M | - |
Forbes Medi-Tech, Inc.
Forbes Medi-Tech, Inc. Pharmaceuticals: MajorHealth Technology Forbes Medi-Tech, Inc. develops and markets a portfolio of nutraceutical products, including functional foods and supplement for the benefit of all consumers. The company provides value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Rewrite as 'It is a life sciences company focused on evidence-based nutritional solutions. It has successfully developed and commercialized its Reducol(tm) plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower 'LDL' cholesterol levels safely and naturally. It was founded on September 17, 1985 and is headquartered in Vancouver, Canada | 11 years |
| Lilyanna C. Yang | M | - |
Forbes Medi-Tech, Inc.
Forbes Medi-Tech, Inc. Pharmaceuticals: MajorHealth Technology Forbes Medi-Tech, Inc. develops and markets a portfolio of nutraceutical products, including functional foods and supplement for the benefit of all consumers. The company provides value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Rewrite as 'It is a life sciences company focused on evidence-based nutritional solutions. It has successfully developed and commercialized its Reducol(tm) plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower 'LDL' cholesterol levels safely and naturally. It was founded on September 17, 1985 and is headquartered in Vancouver, Canada | 6 years |
| Donald Buxton | M | - |
Forbes Medi-Tech, Inc.
Forbes Medi-Tech, Inc. Pharmaceuticals: MajorHealth Technology Forbes Medi-Tech, Inc. develops and markets a portfolio of nutraceutical products, including functional foods and supplement for the benefit of all consumers. The company provides value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Rewrite as 'It is a life sciences company focused on evidence-based nutritional solutions. It has successfully developed and commercialized its Reducol(tm) plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower 'LDL' cholesterol levels safely and naturally. It was founded on September 17, 1985 and is headquartered in Vancouver, Canada | - |
| John Nestor | M | - |
Forbes Medi-Tech, Inc.
Forbes Medi-Tech, Inc. Pharmaceuticals: MajorHealth Technology Forbes Medi-Tech, Inc. develops and markets a portfolio of nutraceutical products, including functional foods and supplement for the benefit of all consumers. The company provides value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Rewrite as 'It is a life sciences company focused on evidence-based nutritional solutions. It has successfully developed and commercialized its Reducol(tm) plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower 'LDL' cholesterol levels safely and naturally. It was founded on September 17, 1985 and is headquartered in Vancouver, Canada | 2 years |
| Scott Stump | M | - | - | |
| Jeffrey M. Gross | M | 61 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 4 years |
| Jonathan W. Chen | M | 49 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 6 years |
| Nicola Price | F | - | 9 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 70 | 94.59% |
| United States | 6 | 8.11% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jodi Regts
- Personal Network
